Drug Type Synthetic peptide |
Synonyms- |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | - | 17 Apr 2024 | |
Digestive System Disorders | Discovery | - | 17 Apr 2024 | |
Endocrinology and Metabolic Disease | Discovery | - | 17 Apr 2024 | |
Inflammation | Discovery | - | 17 Apr 2024 | |
Kidney Diseases | Discovery | - | 17 Apr 2024 | |
Skin and Musculoskeletal Diseases | Discovery | - | 17 Apr 2024 |